1. Home
  2. ANIP vs LKFN Comparison

ANIP vs LKFN Comparison

Compare ANIP & LKFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • LKFN
  • Stock Information
  • Founded
  • ANIP 2001
  • LKFN 1872
  • Country
  • ANIP United States
  • LKFN United States
  • Employees
  • ANIP N/A
  • LKFN N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • LKFN Major Banks
  • Sector
  • ANIP Health Care
  • LKFN Finance
  • Exchange
  • ANIP Nasdaq
  • LKFN Nasdaq
  • Market Cap
  • ANIP 1.4B
  • LKFN 1.5B
  • IPO Year
  • ANIP N/A
  • LKFN 1997
  • Fundamental
  • Price
  • ANIP $66.15
  • LKFN $64.55
  • Analyst Decision
  • ANIP Strong Buy
  • LKFN Buy
  • Analyst Count
  • ANIP 8
  • LKFN 2
  • Target Price
  • ANIP $80.13
  • LKFN $65.00
  • AVG Volume (30 Days)
  • ANIP 246.6K
  • LKFN 158.6K
  • Earning Date
  • ANIP 08-05-2025
  • LKFN 07-25-2025
  • Dividend Yield
  • ANIP N/A
  • LKFN 3.08%
  • EPS Growth
  • ANIP N/A
  • LKFN N/A
  • EPS
  • ANIP N/A
  • LKFN 3.50
  • Revenue
  • ANIP $674,068,000.00
  • LKFN $236,268,000.00
  • Revenue This Year
  • ANIP $30.52
  • LKFN $16.03
  • Revenue Next Year
  • ANIP $7.40
  • LKFN $4.31
  • P/E Ratio
  • ANIP N/A
  • LKFN $18.55
  • Revenue Growth
  • ANIP 30.27
  • LKFN N/A
  • 52 Week Low
  • ANIP $52.50
  • LKFN $50.00
  • 52 Week High
  • ANIP $77.00
  • LKFN $78.61
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 58.88
  • LKFN 69.71
  • Support Level
  • ANIP $63.17
  • LKFN $62.56
  • Resistance Level
  • ANIP $66.18
  • LKFN $65.72
  • Average True Range (ATR)
  • ANIP 1.77
  • LKFN 1.95
  • MACD
  • ANIP 0.07
  • LKFN 0.48
  • Stochastic Oscillator
  • ANIP 75.27
  • LKFN 92.03

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

Share on Social Networks: